Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | MC4R | P32245 | 1/20 | 0.31 |
| ▸ | MC5R | P33032 | 1/20 | 0.31 |
| ▸ | MC3R | P41968 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.30 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16247194 | 0.90 | MAOB (0.37) | SIGMAR1MME | |
| SCHEMBL16428941 | 0.90 | SIGMAR1 (0.43) | SIGMAR1MC4RMC5RMC3R | |
| Hydrochloric Acid SCHEMBL16247175 | 0.89 | SIGMAR1 (0.42) | SIGMAR1 | |
| SCHEMBL16266913 | 0.87 | SIGMAR1 (0.45) | SIGMAR1CNR1MC4RMC5RMC3R | |
| SCHEMBL18223038 | 0.87 | SIGMAR1 (0.38) | SIGMAR1CNR1MC4RMC5RMC3R | |
| SCHEMBL16429460 | 0.87 | PRKCD (0.36) | SIGMAR1 | |
| SCHEMBL18223042 | 0.86 | SIGMAR1 (0.39) | SIGMAR1MC4RMC5RMC3R | |
| SCHEMBL16429108 | 0.85 | CHRNB2 (0.39) | SIGMAR1MC4RMC5RMC3R | |
| SCHEMBL16429474 | 0.85 | PRMT3 (0.40) | SIGMAR1 | |
| SCHEMBL16429512 | 0.82 | SYK (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | CURZA GLOBAL, LLC | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160330962-A1 | COMPOSITIONS COMPRISING A BIOCIDAL POLYAMINE | SRM, SMS, SMOX | SIGMAR1 1551/4885CNR1 4006/4885MC4R 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.